Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
EBIATLong-Term Debt IssuancesShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Quantum Genesis AI (QTZM) Cost of Revenue (2016 - 2018)

Quantumzyme's Cost of Revenue history spans 4 years, with the latest figure at $29007.0 for Q2 2018.

  • For Q2 2018, Cost of Revenue rose 4.35% year-over-year to $29007.0; the TTM value through Jul 2018 reached $89345.0, down 15.59%, while the annual FY2018 figure was $89345.0, 15.59% down from the prior year.
  • Cost of Revenue reached $29007.0 in Q2 2018 per QTZM's latest filing, down from $31118.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $31118.0 in Q1 2018 to a low of $18217.0 in Q3 2017.
  • Average Cost of Revenue over 4 years is $28013.1, with a median of $29181.0 recorded in 2017.
  • The largest YoY upside for Cost of Revenue was 17.78% in 2017 against a maximum downside of 38.04% in 2017.
  • A 4-year view of Cost of Revenue shows it stood at $30136.0 in 2015, then rose by 1.71% to $30651.0 in 2016, then dropped by 4.67% to $29220.0 in 2017, then dropped by 0.73% to $29007.0 in 2018.
  • Per Business Quant, the three most recent readings for QTZM's Cost of Revenue are $29007.0 (Q2 2018), $31118.0 (Q1 2018), and $29220.0 (Q4 2017).